Results 71 to 80 of about 31,072 (141)

Alopecia Areata Universalis in an Infant

, 2001
Background: Alopecia areata (AA) is common during childhood and rarely reported in infants. The four reported cases of AA in infants all exhibited circumscribed patches of alopecia that appeared at birth or shortly thereafter. Objective: We report a case
Guy A. Rouleau, I. Paul Rappaport, J. Andrew Carlson, Judith Mysliborski, Jo Anne LaRow   +4 more
core   +1 more source

Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity—Report of a Case and Review of the Literature

Frontiers in Neurology, 2017
Secondary autoimmunity is the most frequent adverse event occurring in almost every other alemtuzumab-treated multiple sclerosis patient. We report a case of a patient with relapsing-remitting multiple sclerosis who reported smooth, circular areas of ...
Julian Zimmermann, Timo Buhl, Marcus Müller   +2 more
doaj   +1 more source

Do Alopecia Areata and Hair Colour Have a Shared Genetic Component?

Experimental Dermatology, Volume 35, Issue 6, June 2026.
The aim of our study was to determine whether hair colour and the risk of developing alopecia areata (AA) share a genetic basis. While we found no evidence for a broadly shared polygenic background, our analyses revealed suggestive evidence that genetically predicted blond hair is associated with a reduced risk of AA. ABSTRACT Alopecia areata (AA) is a
Leonie Rieger‐Molitor, Carlo Maj, Silke Redler, Yasmina Gossmann, Stephan Ripke, Lynn Pethukova, Angela M. Christiano, Markus M. Nöthen, F. Buket Basmanav, Regina C. Betz   +9 more
wiley   +1 more source

Alopecia Areata Universalis in a Dog

Embargado hasta 01/01/2100.Background - Alopecia areata is a T-cell mediated autoimmune disease that occurs in humans and various other mammalian species.
Ginel, Pedro J., Zafra, Rafael, Pérez-Aranda, María, Mozos Mora, Elena, Blanco, Beatriz   +4 more
core   +1 more source

Alopecia Risk With GLP‐1 Receptor Agonists: A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1‐RAs), a class of drugs indicated for diabetes mellitus and weight control, have been implicated in alopecia. We mined data from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) to better understand the relationship between alopecia and GLP‐1‐RAs.
Aditya K. Gupta, Elizabeth Teasell, Mary A. Bamimore, Paradi Mirmirani, Mesbah Talukder   +4 more
wiley   +1 more source

Severe Onycholysis in a Card Illusionist with Alopecia Areata Universalis

, 2013
In patients with alopecia areata (AA), nail abnormalities due to nail matrix inflammation are common and usually not severe. We report the case of a 23-year-old man with AA universalis, who developed severe abnormalities of all his fingernails.
Venturi, Michela, Chiacchio, Nilton Chiacchio, Tosti, Antonella, Pazzaglia, Massimiliano   +3 more
core   +1 more source

Co‐Occurrence of Agminated Lentigines, Café‐Au‐Lait Macules, and Vitiligo: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Lentigines, café‐au‐lait macules (CALMs), and vitiligo are pigmentary disorders that seldom occur together in a single individual. Their co‐occurrence may indicate underlying genetic syndromes requiring differential diagnosis. We report an 18‐year‐old male who developed CALMs at age 11, agminated lentigines at age 13, and vitiligo on the right
Xinxin Lei, Bo Xie
wiley   +1 more source

Dupilumab's bidirectional effects on alopecia areata: A systematic review

JAAD Reviews
Background: Dupilumab inhibits interleukin-4 and interleukin-13 signaling and is used for atopic dermatitis and other type 2 inflammatory diseases, but its relationship with alopecia areata (AA) remains paradoxical. Objective: To characterize AA outcomes
Gerardo Guilarte, BS, Connor Gill, BS, Lucie Joerg, BA, Dongwon Lee, BS, Shayan Khwaja, BS, Sonal Choudhary, MD   +5 more
doaj   +1 more source

ALOPECIA UNIVERSAL COMO PRESENTACIÓN INICIAL DE UN SÍNDROME POLIGLANDULAR AUTOINMUNE REPORTE DE CASO

Medicina, 2018
Introducción: La alopecia universalis es la pérdida de pelo en todo el cuerpo por destrucción del folículo capilar. En la etiología se describen factores 1. Genéticos como alteración del cromosoma 18, haplotipos HLA DQ3, DQ7, DR4 y DR11. 2.
Liliana M. Mejía Zapata, Angie M. Cárdenas Silva   +1 more
doaj  

Supplemental Results for "Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta-analysis"

, 2019
Supplemental Table 1 and Results for "Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta ...
Silverberg, J
core   +2 more sources